APOL1 genotype associated risk for preeclampsia in African populations: Rationale and protocol design for studies in women of African ancestry in resource limited settings.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
04
2022
accepted:
09
11
2022
entrez:
29
12
2022
pubmed:
30
12
2022
medline:
3
1
2023
Statut:
epublish
Résumé
Women of African ancestry are highly predisposed to preeclampsia which continues to be a major cause of maternal death in Africa. Common variants in the APOL1 gene are potent risk factor for a spectrum of kidney disease. Recent studies have shown that APOL1 risk variants contribute to the risk of preeclampsia. The aim of the study is to understand the contribution of APOL1 risk variants to the development of preeclampsia in pregnant women in Ghana. The study is a case-control design which started recruitment in 2019 at the Korle Bu Teaching Hospital in Ghana. The study will recruit pregnant women with a target recruitment of 700 cases of preeclampsia and 700 normotensives. Clinical and demographic data of mother- baby dyad, with biospecimens including cord blood and placenta will be collected to assess clinical, biochemical and genetic markers of preeclampsia. The study protocol was approved by Korle Bu Teaching Hospital Institutional Review Board (Reference number: KBTH-IRB/000108/2018) on October 11, 2018. As of December 2021, a total of 773 mother-baby pairs had been recruited and majority of them had complete entry of data for analysis. The participants are made up of 384 preeclampsia cases and 389 normotensive mother-baby dyad. The mean age of participants is 30.69 ± 0.32 years for cases and 29.95 ± 0.32 for controls. Majority (85%) of the participants are between 20-30years. At booking, majority of cases had normal blood pressure compared to the time of diagnosis where 85% had a systolic BP greater than 140mmHg and a corresponding 82% had diastolic pressure greater than 90mmHg. Our study will ultimately provide clinical, biochemical and genotypic data for risk stratification of preeclampsia and careful monitoring during pregnancy to improve clinical management and outcomes.
Sections du résumé
BACKGROUND
Women of African ancestry are highly predisposed to preeclampsia which continues to be a major cause of maternal death in Africa. Common variants in the APOL1 gene are potent risk factor for a spectrum of kidney disease. Recent studies have shown that APOL1 risk variants contribute to the risk of preeclampsia. The aim of the study is to understand the contribution of APOL1 risk variants to the development of preeclampsia in pregnant women in Ghana.
METHODS
The study is a case-control design which started recruitment in 2019 at the Korle Bu Teaching Hospital in Ghana. The study will recruit pregnant women with a target recruitment of 700 cases of preeclampsia and 700 normotensives. Clinical and demographic data of mother- baby dyad, with biospecimens including cord blood and placenta will be collected to assess clinical, biochemical and genetic markers of preeclampsia. The study protocol was approved by Korle Bu Teaching Hospital Institutional Review Board (Reference number: KBTH-IRB/000108/2018) on October 11, 2018.
PRELIMINARY RESULTS
As of December 2021, a total of 773 mother-baby pairs had been recruited and majority of them had complete entry of data for analysis. The participants are made up of 384 preeclampsia cases and 389 normotensive mother-baby dyad. The mean age of participants is 30.69 ± 0.32 years for cases and 29.95 ± 0.32 for controls. Majority (85%) of the participants are between 20-30years. At booking, majority of cases had normal blood pressure compared to the time of diagnosis where 85% had a systolic BP greater than 140mmHg and a corresponding 82% had diastolic pressure greater than 90mmHg.
CONCLUSION
Our study will ultimately provide clinical, biochemical and genotypic data for risk stratification of preeclampsia and careful monitoring during pregnancy to improve clinical management and outcomes.
Identifiants
pubmed: 36580463
doi: 10.1371/journal.pone.0278115
pii: PONE-D-22-07467
pmc: PMC9799323
doi:
Substances chimiques
Apolipoprotein L1
0
APOL1 protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0278115Subventions
Organisme : NIDDK NIH HHS
ID : U54 DK116913
Pays : United States
Informations de copyright
Copyright: © 2022 Osafo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BJOG. 2014 Nov;121(12):1492-500
pubmed: 24758368
Am J Hum Genet. 2018 Sep 6;103(3):367-376
pubmed: 30173819
Hypertens Pregnancy. 2015 Nov;34(4):506-515
pubmed: 26636247
Semin Perinatol. 2012 Feb;36(1):56-9
pubmed: 22280867
Pregnancy Hypertens. 2017 Apr;8:37-41
pubmed: 28501277
Adv Chronic Kidney Dis. 2014 Sep;21(5):426-33
pubmed: 25168832
Am J Kidney Dis. 2020 Jul;76(1):100-108
pubmed: 32354559
Am J Obstet Gynecol. 2001 May;184(6):1211-7
pubmed: 11349190
Trends Cardiovasc Med. 2008 Jul;18(5):186-94
pubmed: 18790389
Lancet. 2005 Feb 26-Mar 4;365(9461):785-99
pubmed: 15733721
Science. 2010 Aug 13;329(5993):841-5
pubmed: 20647424
BMC Med Genet. 2020 May 20;21(1):110
pubmed: 32434471
Eur J Public Health. 2015 Aug;25(4):620-5
pubmed: 25587005
J Am Soc Nephrol. 2015 Nov;26(11):2882-90
pubmed: 25788523
Circulation. 2013 Feb 12;127(6):681-90
pubmed: 23401113
Am J Obstet Gynecol. 2014 Jun;210(6):510-520.e1
pubmed: 24184340
Kidney Int. 2013 Jan;83(1):114-20
pubmed: 22832513
J Am Soc Nephrol. 2016 Dec;27(12):3600-3610
pubmed: 27026370
J Clin Hypertens (Greenwich). 2019 Apr;21(4):479-488
pubmed: 30848083
Biomed Pharmacother. 2019 Jan;109:408-416
pubmed: 30399576
Nephrol Dial Transplant. 2017 Dec 01;32(12):2051-2058
pubmed: 27638911
Hypertension. 2003 Mar;41(3):437-45
pubmed: 12623940
Int Urol Nephrol. 2013 Apr;45(2):485-94
pubmed: 22956460
Nephron Clin Pract. 2013;123(1-2):123-8
pubmed: 23860441
Eur J Obstet Gynecol Reprod Biol X. 2020 Oct 09;9:100119
pubmed: 33103113
Lancet. 2010 Aug 21;376(9741):631-44
pubmed: 20598363
BMC Genet. 2015 Jun 26;16:69
pubmed: 26112018
Eur J Obstet Gynecol Reprod Biol. 2020 Mar;246:129-133
pubmed: 32018194
BMC Physiol. 2017 Mar 29;17(1):5
pubmed: 28356151